Shining a light on dementia

Did you know dementia is the second leading cause of death in Australia, affecting close to half a million Australians? In the absence of a medical breakthrough, this number is set to double in the next 25 years. What exactly is dementia? Dementia is not one specific disease, but rather is an umbrella term describing…

Read More

Australian healthcare industry supports outcomes of Federal Budget 2020-21

Industry leaders across pharmaceutical, med-tech, biotech, pharmacy and community health have been quick to praise the Government’s record four-year injection of $467 billion into health announced in last night’s 2020-2021 Budget. This includes $2.8 billion for Australia’s medicines industry – the first significant investment since May 2018 and a considerable win for Medicines Australia (MA) and…

Read More

Prostate Cancer Awareness Month

With over 16,700 new cases of prostate cancer every year, it is Australia’s most commonly diagnosed men’s cancer. Tragically, the disease claims the lives of more than 3,300 men each year. September is Prostate Cancer Awareness Month and Aussies are being invited to participate in ‘The Long Run’ – running, walking or wheeling 72km throughout…

Read More

Telehealth services extended for six months

The Federal Government announced yesterday they will be extending the Medicare-subsidised rebates for COVID-19 telehealth consultations for a further six months, offering ongoing assistance to patients and medical practices during the global health pandemic. The telehealth scheme, first implemented at the end of March when the pandemic sent Australia into lockdown, was due to lapse…

Read More

Virtual HCP advisory board spearheading industry digital transformation

Today, VIVA! Communications partnered with the team at Rumi to launch their innovative digital advisory board platform, designed to facilitate insight-generating, ‘any time’ HCP advisory boards in a time-efficient, cost-effective, multilingual, secure and Code compliant way. The online platform, which is the brainchild of Australian pharmaceutical Digerati, is promising to transform the pharmaceutical industry’s healthcare…

Read More